65. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
11. - 14. Mai 2014, Dresden
Poster Sessions
P IVc Oncology: Glioma Experimental Investigations 2
Meeting Abstract
(P 042)
[Volltext]
Expression of Kv10.1 and KCNN3 potassium ion channels in gliomas
Ninkovic M, Sperling S, Sachkova A, Martin S, Pardo LA, Martínez-Olivera R, Rohde V[Volltext]
Meeting Abstract
(P 055)
[Volltext]
The epigenetic route of temozolomide action in brain tumor cells
Barciszewska AM, Nowak S, Wyszko E, Piwecka M, Barciszewska MZ[Volltext]
Meeting Abstract
(P 044)
[Volltext]
Gene expression level of different gene sets varies between de-novo and recurrent grade III glioma
Perrech M, Röhn G, Goldbrunner R, Timmer M[Volltext]
Meeting Abstract
(P 045)
[Volltext]
Quantitative analysis of IDH1 mut expression level in low-grade glioma and secondary high-grade glioma by RT-PCR and Western Blot analysis
Perrech M, Dreher L, Röhn G, Goldbrunner R, Timmer M[Volltext]
Meeting Abstract
(P 046)
[Volltext]
Identification of candidate genes associated with malignant transformation of IDH-mutated low-grade astrocytomas using genome-wide copy number variation analysis
Juratli TA, Geiger KD, Krex D, Schackert G, Chakravarti A, Lautenschlaeger T[Volltext]
Meeting Abstract
(P 047)
[Volltext]
Histone deacetylase inhibitors sensitize glioblastoma cells to EGFR-directed therapy with tyrosine kinase inhibitors
Liffers K, Riethdorf S, Galli R, Westphal M, Lamszus K, Schulte A[Volltext]
Meeting Abstract
(P 048)
[Volltext]
Genome-wide CNV analysis identifies loci putatively associated with delayed time to first recurrence in IDH-mutant low-grade astrocytomas
Juratli TA, Lautenschlaeger T, Krex D, Geiger K, Chakravarti A, Schackert G[Volltext]
Meeting Abstract
(P 049)
[Volltext]
RNAi-mediated knock down of Survivin induces DNA damage in U87-MG glioma cells
Wiedemuth R, Conde M, Schackert G, Temme A[Volltext]
Meeting Abstract
(P 050)
[Volltext]
Targeting PSCA-positive tumor cells using a novel natural killer cell chimeric antigen receptor consisting of NKp46 and alphaPSCA
Michen S, Schackert G, Temme A[Volltext]
